← All trials
NCT01559753
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 1998
- Primary completion
- Sep 1, 2002
- Completion date
- Nov 1, 2002
- First posted
- —
- Last posted
- —
- Enrollment
- 225
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of Franche-ComtéLead sponsor
- SmithKline BeechamCollaborator
- GlaxoSmithKlineCollaborator
- University of Franche-ComtéOverall official - principal investigator
- French Society for Intensive CareCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.